Compare LUCD & NRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LUCD | NRO |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 183.5M | 199.6M |
| IPO Year | 2021 | 2003 |
| Metric | LUCD | NRO |
|---|---|---|
| Price | $1.27 | $2.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $3.94 | N/A |
| AVG Volume (30 Days) | ★ 659.4K | 316.7K |
| Earning Date | 03-26-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,346,000.00 | N/A |
| Revenue This Year | $7.69 | N/A |
| Revenue Next Year | $155.47 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 79.00 | N/A |
| 52 Week Low | $0.95 | $2.75 |
| 52 Week High | $1.80 | $3.37 |
| Indicator | LUCD | NRO |
|---|---|---|
| Relative Strength Index (RSI) | 40.44 | 32.54 |
| Support Level | $1.01 | N/A |
| Resistance Level | $1.52 | $3.10 |
| Average True Range (ATR) | 0.06 | 0.04 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 14.38 | 2.50 |
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. Under normal market conditions, the Fund invests at least 90% of its total assets in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by real estate companies, including real estate investment trusts ("REITs").